Investment
Features
FeesSafety
Academy
More
Pluang+

Rocket Lab eyes 90% upside as it expands beyond launches with Iridium deal and defense contracts.

Analyst Insights
17 Sep 2026
24/7 Wall Street
View Source
Bullish
Rocket Lab eyes 90% upside as it expands beyond launches with Iridium deal and defense contracts.

Rocket Lab is transforming from a small-launch specialist into a comprehensive space company, driven by its pending acquisition of Iridium and new defense contracts. Despite a recent share price drop, the company reported record Q2 revenue of $234 million, up 62% year-over-year, and a backlog of $2.36 billion. The stock has a 24/7 Wall St. price target of $120.88, implying a 90% upside, though risks include launch delays and integration challenges. Key catalysts include the Neutron rocket pad delivery and the closing of the Iridium deal, which could significantly boost the company's valuation.

Rocket Lab's stock is trading at USD 67.92 on Pluang as of Sep 18, 2026 01:12 WIB, showing a strong 1-day gain of 6.62%. This price sits well above its 52-week low of USD 39.48 but remains significantly below the 52-week high of USD 150.23, highlighting considerable room for growth. Despite recent volatility and a mixed order activity with 56% selling and 44% buying, the market cap stands robust at $40.73 billion, reflecting substantial investor interest in the company's expanding space ventures.

More News (RKLB)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App